Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin C

This article was originally published in The Tan Sheet

Executive Summary

Ingestion of megadoses of vitamin C inhibited elevation of glucocorticoid hormone levels, limited reduction of adrenal ascorbic acid and reduced other typical indicators of physical and emotional stress in rats, researchers report in a study released Aug. 22 at the American Chemical Society's annual meeting in New Orleans. Rats were fed 100 mg of vitamin C twice daily for three weeks, and stress was produced daily. Vitamin C treatment elevated levels of circulating IgG antibody to a lesser extent in the stressed subjects than in the non-stressed subjects, suggesting an increased tolerance for vitamin C under stressful conditions, the investigators say. The researchers conclude vitamin C may reduce the debilitation and illness associated with chronic stress by inhibiting glucocorticoid secretion and immunosuppression

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel